Anna's Daybreak News

_{Just facts, you think for yourself}

Thursday, 5:23 AM

September 25, 2025

Good morning news friend! Follow today’s key stories as they shape the world of tomorrow. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Shooting at Dallas ICE Facility

A shooting at a Dallas ICE facility resulted in one death and two critical injuries. The gunman, 29-year-old Joshua Jahn, died from a self-inflicted wound after targeting detainees in a van with a bolt-action rifle.

Anti-ICE messaging was found on ammunition, suggesting an ideological motive. This marks the third shooting at an ICE facility in Texas recently, raising concerns over political violence.

One injured individual is a Mexican national receiving consular assistance. Increased security measures at ICE facilities have been implemented, with Homeland Security Secretary Kristi Noem condemning the violence and its links to hateful rhetoric.

Sources: AP News, Reuters, Reuters, NYTimes, Dhs.

Government Shutdown Looms

The White House has directed federal agencies to prepare for potential job cuts amid a looming government shutdown, which could lead to layoffs instead of the usual furloughs.

This change increases uncertainty for federal employees already facing reductions. The Office of Management and Budget (OMB) highlights a funding lapse projected for September 30, 2025, as Congressional Democrats block a clean funding bill, demanding improved health care provisions.

Senate Minority Leader Chuck Schumer and House Minority Leader Hakeem Jeffries criticize the OMB memo, calling it intimidation.

Sources: Bloomberg, AP News, Aol, WallStreetJournal.

Delta’s Toxic Fumes

Delta Airlines is replacing engine units to tackle increased toxic fumes detected in its aircraft, responding to growing passenger health concerns and scrutiny over air quality.

This proactive measure aims to improve safety and air quality on flights. Following this announcement, Delta's stock dropped by 1.77%, reflecting market reactions.

Analysts believe that these changes may stabilize the stock in the long run as safety improves.

Sources: Tradingview, WallStreetJournal.

Apple vs. EU

Apple has raised concerns over the EU's Digital Markets Act (DMA), claiming it delays feature rollouts and increases privacy risks. Features like iPhone Mirroring and Live Translation have been postponed due to compatibility challenges with third-party devices.

Apple urged EU regulators to reconsider the DMA, asserting it complicates operations and compromises user data security. In April 2025, the EU fined Apple €500 million for non-compliance, stemming from restrictions on developer communication outside the App Store.

Apple argued that the DMA creates a "riskier, less intuitive" user experience by allowing unauthorized apps, and it called for the repeal or reform of the regulation.

Sources: Reuters, Bloomberg, EuroNews, Rfi.

Harnessing Brown Fat

Researchers at Washington University found that brown fat plays a key role in metabolism regulation, offering avenues for obesity treatment.

Mice lacking the protein ACOX2 showed reduced heat production and increased obesity risk on high-fat diets, while those with higher ACOX2 levels showed improved heat production and insulin sensitivity.

The study identified peroxisomes as crucial heat-generating elements in brown fat. Infrared imaging revealed lower body temperatures in ACOX2-deficient mice during cold exposure.

Targeting fatty acids that activate ACOX2 could enhance metabolic health in humans, potentially aiding weight loss and management.

Sources: WashU, SciTechDaily.

Stopping Huntington's Disease

Researchers in the UK have introduced AMT-130, a gene therapy for Huntington's disease, that led to a 75% reduction in disease progression in a trial with 29 patients over three years.

The high-dose group had significantly decreased neurodegeneration biomarkers. This treatment involves a complex brain surgery to deliver genetic material via a harmless virus, targeting the toxic huntingtin protein.

Approximately 75,000 individuals in the UK, US, and Europe are affected. Although promising, the therapy is expected to be expensive and may face accessibility challenges.

UniQure plans to apply for FDA approval in early 2026, with future trials exploring prevention strategies for at-risk individuals.

Sources: Sciencealert, BBC, UCL, ABC.

“Even a virtue can be stretched so thin it turns into a vice; a man ought to enjoy the sweetness of a thing, and then have the plain horse sense to stop before he gets to the rind.”

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

• The Healthcare Hammer

• The Resilient Retirement

• Inflammation Crisis

• AI Proof Professionals

Baked with love,

Anna Eisenberg ❤️